Free Trial

Oruka Therapeutics (ORKA) Institutional Ownership

Oruka Therapeutics logo
$12.61 +0.81 (+6.86%)
Closing price 04:00 PM Eastern
Extended Trading
$12.62 +0.02 (+0.12%)
As of 07:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Oruka Therapeutics (NASDAQ:ORKA)

Current
Institutional Ownership
Percentage
56.44%
Number of
Institutional Buyers
(last 12 months)
42
Total
Institutional Inflows
(last 12 months)
$409.03M
Number of
Institutional Sellers
(last 12 months)
6
Total
Institutional Outflows
(last 12 months)
$15.14M
Get ORKA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Oruka Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

ORKA Institutional Buying and Selling by Quarter

Oruka Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/16/2025Goldman Sachs Group Inc.244,199$2.51M0.0%N/A0.652%
5/16/2025ADAR1 Capital Management LLC132,780$1.36M0.3%N/A0.355%
5/15/2025Redmile Group LLC386,963$3.97M0.4%-6.0%1.034%
5/15/2025Braidwell LP1,572,426$16.13M0.6%+37.0%4.200%
5/15/2025OMERS ADMINISTRATION Corp44,900$461K0.0%+126.8%0.120%
5/14/2025Affinity Asset Advisors LLC545,362$5.60M0.5%+47.9%1.457%
5/14/2025AlphaQuest LLC16,335$168K0.0%N/A0.044%
5/14/2025Candriam S.C.A.116,698$1.20M0.0%N/A0.312%
5/14/2025Wellington Management Group LLP87,501$898K0.0%-8.0%0.234%
5/8/2025Jefferies Financial Group Inc.405,029$4.16M0.0%+15.7%1.082%
5/7/2025TD Asset Management Inc45,876$471K0.0%-51.7%0.123%
4/28/2025Cannon Global Investment Management LLC19,000$195K0.3%N/A0.051%
3/24/2025Wellington Management Group LLP95,089$1.84M0.0%+15.8%0.254%
2/27/2025Jefferies Financial Group Inc.350,029$6.79M0.0%N/A1.000%
2/19/2025Toronto Dominion Bank58,332$1.13M0.0%N/A0.167%
2/18/2025Frazier Life Sciences Management L.P.583,327$11.31M0.5%+22.2%1.667%
2/17/2025VR Adviser LLC3,285,620$63.71M4.4%+6.5%9.387%
2/17/2025Squarepoint Ops LLC12,175$236K0.0%N/A0.035%
2/17/2025Toronto Dominion Bank58,332$1.13M0.0%N/A0.167%
2/17/2025RTW Investments LP1,945,649$37.73M0.6%+5.1%5.559%
2/17/2025Point72 Asset Management L.P.360,732$7.00M0.0%-25.2%1.031%
2/17/2025Polar Capital Holdings Plc550,000$10.66M0.1%N/A1.571%
2/17/2025Paradigm Biocapital Advisors LP819,660$15.89M0.6%+13.9%2.342%
2/17/2025OMERS ADMINISTRATION Corp19,800$384K0.0%N/A0.057%
2/17/2025Millennium Management LLC30,305$588K0.0%N/A0.087%
2/17/2025Janus Henderson Group PLC849,410$16.42M0.0%+259.7%2.427%
2/17/2025Jefferies Financial Group Inc.350,029$6.79M0.0%N/A1.000%
2/17/2025Fairmount Funds Management LLC3,371,922$65.38M6.5%+5.0%9.634%
2/17/2025Deep Track Capital LP750,000$14.54M0.5%-39.3%2.143%
2/17/2025Braidwell LP1,147,676$22.25M0.7%+122.5%3.279%
2/17/2025Blackstone Inc.240,174$4.66M0.0%N/A0.686%
2/17/2025Allostery Investments LP20,000$388K0.4%N/A0.057%
2/17/2025683 Capital Management LLC33,875$657K0.0%N/A0.097%
2/14/2025Jane Street Group LLC17,706$343K0.0%N/A0.051%
2/14/2025Northern Trust Corp64,044$1.24M0.0%N/A0.183%
2/14/2025Adage Capital Partners GP L.L.C.69,200$1.34M0.0%-65.4%0.198%
2/14/2025Price T Rowe Associates Inc. MD1,326,893$25.73M0.0%+374.5%3.791%
2/14/2025B Group Inc.20,000$388K0.2%N/A0.057%
2/13/2025SR One Capital Management LP430,330$8.34M2.0%+14.7%1.230%
2/13/2025Affinity Asset Advisors LLC368,698$7.15M1.0%+5.4%1.053%
Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad)

Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.

For the moment, you can watch this interview free of charge – just click here.
2/13/2025Barclays PLC74,583$1.45M0.0%N/A0.213%
2/13/2025Kennedy Capital Management LLC60,494$1.17M0.0%N/A0.173%
2/13/2025FMR LLC5,512,300$106.88M0.0%+17.7%15.749%
2/12/2025Geode Capital Management LLC342,418$6.64M0.0%+2,348.6%0.978%
2/12/2025Wellington Management Group LLP95,089$1.84M0.0%+15.8%0.272%
2/12/2025JPMorgan Chase & Co.2,800$54K0.0%N/A0.008%
2/11/2025Vanguard Group Inc.1,610,651$31.23M0.0%+4,161.2%4.602%
2/6/2025Charles Schwab Investment Management Inc.15,608$303K0.0%N/A0.045%
1/31/2025AlphaCentric Advisors LLC6,140$119K0.1%N/A0.018%
1/24/2025China Universal Asset Management Co. Ltd.7,421$144K0.0%N/A0.021%
11/27/2024Franklin Resources Inc.720,547$17.66M0.0%N/A2.059%
11/16/2024Geode Capital Management LLC13,984$343K0.0%N/A1.156%
11/15/2024Frazier Life Sciences Management L.P.477,327$11.70M0.5%N/A39.449%
11/15/2024Wellington Management Group LLP82,137$2.01M0.0%N/A6.788%
11/15/2024RTW Investments LP1,850,648$45.36M0.7%N/A152.946%
11/15/2024Redmile Group LLC411,728$10.09M0.6%N/A34.027%
11/15/2024Point72 Asset Management L.P.482,330$11.82M0.0%N/A39.862%
11/15/2024Janus Henderson Group PLC236,116$5.84M0.0%N/A19.514%
11/14/2024Braidwell LP515,726$12.64M0.4%N/A42.693%
11/13/2024Great Point Partners LLC514,659$12.61M3.7%N/A42.534%
11/13/2024FMR LLC4,682,300$114.76M0.0%N/A386.967%
11/13/2024The Manufacturers Life Insurance Company42,298$1.04M0.0%N/A3.496%
(Data available from 1/1/2016 forward)

ORKA Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ORKA shares?

During the previous two years, 45 institutional investors and hedge funds held shares of Oruka Therapeutics. The most heavily invested institutionals were FMR LLC ($106.88M), Fairmount Funds Management LLC ($65.38M), VR Adviser LLC ($63.71M), RTW Investments LP ($37.73M), Vanguard Group Inc. ($31.23M), Price T Rowe Associates Inc. MD ($25.73M), and Franklin Resources Inc. ($17.66M).Learn more on Oruka Therapeutics' institutional investors.

What percentage of Oruka Therapeutics' stock is owned by institutional investors?

56.44% of Oruka Therapeutics' stock is owned by institutional investors. Learn more on ORKA's institutional investor holdings.

Which institutional investors have been buying Oruka Therapeutics' stock?

Of the 42 institutional investors that purchased Oruka Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: FMR LLC ($5.51M), RTW Investments LP ($1.95M), Vanguard Group Inc. ($1.57M), Braidwell LP ($1.57M), Price T Rowe Associates Inc. MD ($1.05M), Janus Henderson Group PLC ($849.41K), and Jefferies Financial Group Inc. ($755.06K).

How much institutional buying is happening at Oruka Therapeutics?

Institutional investors have bought a total of 19,016,716 shares in the last 24 months. This purchase volume represents approximately $409.03M in transactions.

Which of Oruka Therapeutics' major shareholders have been selling company stock?

The following institutional investors have sold Oruka Therapeutics stock in the last 24 months: Deep Track Capital LP ($485.19K), Adage Capital Partners GP L.L.C. ($130.80K), Point72 Asset Management L.P. ($121.60K), TD Asset Management Inc ($49.20K), Redmile Group LLC ($24.77K), and Wellington Management Group LLP ($7.59K).

How much institutional selling is happening at Oruka Therapeutics?

Institutional investors have sold a total of 819,138 shares in the last 24 months. This volume of shares sold represents approximately $15.14M in transactions.



This page (NASDAQ:ORKA) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners